Proteomic Analysis of the Molecular Mechanism of Lovastatin Inhibiting the Growth of Nasopharyngeal Carcinoma Cells

Metabolic abnormalities are one of the essential features of tumors. Increasingly more studies have shown that lovastatin, a lipid-reducing drug, has visible inhibitory effects on tumors, but it has not been reported in nasopharyngeal carcinoma. In this paper, we explored the effects of lovastatin o...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Cancer
Autors principals: Mo, Yongzhen, Wang, Yumin, Xiong, Fang, Ge, Xiaolu, Li, Zheng, Li, Xiayu, Li, Yong, Li, Xiaoling, Xiong, Wei, Li, Guiyuan, Zeng, Zhaoyang, Guo, Can
Format: Artigo
Idioma:Inglês
Publicat: Ivyspring International Publisher 2019
Matèries:
Research Paper
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6584415/
https://ncbi.nlm.nih.gov/pubmed/31258737
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7150/jca.30454
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars